Pancreatic Cancer

• Participant Clinical Case Discussion: A case of Highly Proliferated but Well Differentiated Pancreatic NET
• Participant Clinical Case Discussion: Pancreatic Neuroendocrine Tumour, a Challenging Case
• CPI-613 Plus Modified FOLFIRINOX ‘Well Tolerated’ For Metastatic Pancreatic Cancer
• Nab-Paclitaxel With Leucovorin–Fluorouracil Shows Metastatic Pancreas Cancer Promise
• ViP Rules Out Advanced Pancreatic Cancer OS Benefit For Vandetanib Plus Gemcitabine
• Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors
• Dual Targeted Molecular Therapy Fails To Improve Metastatic Pancreatic Cancer OS
• Efficacy and safety of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02, BAX-2398) in patients with metastatic pancreatic cancer in Asia: A subgrou...
• Invited Discussant 221PD, 222PD, 223PD, 224PD and 225PD
• Disruption of DNA double strand break repair by VCP inhibition in ovarian and pancreatic cancer
• Predictive value of ERCC1, ERCC2, ERCC4, and glutathione S-transferase P1 for FOLFIRINOX in unresectable pancreatic cancer
• Functional assessment of elderly cancer patients
• Efficacy of chemotherapy in patients with unresectable or metastatic pancreatic acinar cell carcinoma: Potentially improved efficacy with oxaliplat...
• Clinical sequencing system for pancreatic cancer as a laboratory examination
• An evaluation of the anti-cancerous potential of 5-epi-sinuleptolide in pancreatic cancer
• A randomized phase 2 study of nanoliposomal irinotecan (nal-IRI, BAX2398)-containing regimen in Japanese patients with metastatic pancreatic adenoc...
• Oxaliplatin-induced hyperammonemic encephalopathy in metastatic pancreatic cancer, a case report
• Verification of mechanism that CSC markers are implicated in poor prognosis for pancreatic ductal adenocarcinoma
• Identification of novel biomarkers distinguishing pancreatic head cancer from distal cholangiocarcinoma discovered by proteomics analysis
• NOP14 promotes invasion and metastasis by maintaining mutant p53-induced oncogenic signaling in pancreatic cancer
• Effects of nal-IRI (MM-398) ± 5-fluorouracil on quality of life (QoL) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previous...
• Recombination signal binding protein for immunoglobulin-kappa-J region (RBPJ) and Mastermind-like 3 (MAML3) are potential therapeutic targets for p...
• Molecular mechanisms involved in the synergistic interaction of novel formulated curcumin with gemcitabine in pancreatic cancer cells
• First-line chemotherapies with FOLFIRINOX or gemcitabine plus nab-paclitaxel for unresectable pancreatic ductal adenocarcinoma in Japanese daily cl...
• Thromboembolism incidence in patients with pancreatic cancer receiving chemotherapy: A single-institutional retrospective cohort analysis

• « Previous
• 1
• 2
• ...
• 11
• Next »